Certified Advisory Corp’s Esperion Therapeutics ESPR Stock Holding History

Certified Advisory Corp’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1K	Hold	28	–	–	﹤0.01%	721
2020 Q1	$1K	Sell	28 -25	-47%	-$1.32K	﹤0.01%	729
2019 Q4	$3K	Hold	53	–	–	﹤0.01%	694
2019 Q3	$2K	Hold	53	–	–	﹤0.01%	728
2019 Q2	$2K	Buy	53 +25	+89%	+$1.17K	﹤0.01%	742
2019 Q1	$1K	Hold	28	–	–	﹤0.01%	712
2018 Q4	$1K	Hold	28	–	–	﹤0.01%	707
2018 Q3	$1K	Hold	28	–	–	﹤0.01%	743
2018 Q2	$1K	Buy	+28	New	+$1.42K	﹤0.01%	732

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return